PMC:1472690 / 902-1164 JSONTXT

Annnotations TAB JSON ListView MergeView

    bionlp-st-ge-2016-test-proteins

    {"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T311","span":{"begin":12,"end":16},"obj":"Protein"},{"id":"T312","span":{"begin":102,"end":106},"obj":"Protein"},{"id":"T313","span":{"begin":132,"end":155},"obj":"Protein"},{"id":"T314","span":{"begin":156,"end":158},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    bionlp-st-ge-2016-uniprot

    {"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T441","span":{"begin":12,"end":16},"obj":"http://www.uniprot.org/uniprot/P10145"},{"id":"T442","span":{"begin":102,"end":106},"obj":"http://www.uniprot.org/uniprot/P10145"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    GO-MF

    {"project":"GO-MF","denotations":[{"id":"T338","span":{"begin":59,"end":66},"obj":"http://purl.obolibrary.org/obo/GO_0005488"},{"id":"T351","span":{"begin":12,"end":16},"obj":"http://purl.obolibrary.org/obo/GO_0005153"},{"id":"T352","span":{"begin":102,"end":106},"obj":"http://purl.obolibrary.org/obo/GO_0005153"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    GO-CC

    {"project":"GO-CC","denotations":[{"id":"T357","span":{"begin":227,"end":232},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    sentences

    {"project":"sentences","denotations":[{"id":"T195","span":{"begin":32,"end":116},"obj":"Sentence"},{"id":"T196","span":{"begin":117,"end":185},"obj":"Sentence"},{"id":"T9","span":{"begin":32,"end":116},"obj":"Sentence"},{"id":"T10","span":{"begin":117,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    simple1

    {"project":"simple1","denotations":[{"id":"T404","span":{"begin":12,"end":16},"obj":"Protein"},{"id":"T405","span":{"begin":102,"end":106},"obj":"Protein"},{"id":"T406","span":{"begin":132,"end":155},"obj":"Protein"},{"id":"T407","span":{"begin":156,"end":158},"obj":"Protein"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    BioNLP16_DUT

    {"project":"BioNLP16_DUT","denotations":[{"id":"T863","span":{"begin":59,"end":66},"obj":"Binding"},{"id":"T865","span":{"begin":160,"end":170},"obj":"Gene_expression"},{"id":"T866","span":{"begin":120,"end":128},"obj":"Positive_regulation"},{"id":"T836","span":{"begin":12,"end":16},"obj":"Protein"},{"id":"T837","span":{"begin":102,"end":106},"obj":"Protein"},{"id":"T838","span":{"begin":132,"end":155},"obj":"Protein"},{"id":"T839","span":{"begin":156,"end":158},"obj":"Protein"}],"relations":[{"id":"R215","pred":"themeOf","subj":"T865","obj":"T866"},{"id":"R216","pred":"themeOf","subj":"T865","obj":"T866"},{"id":"R345","pred":"themeOf","subj":"T837","obj":"T863"},{"id":"R346","pred":"themeOf","subj":"T838","obj":"T865"},{"id":"R347","pred":"themeOf","subj":"T839","obj":"T865"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    BioNLP16_Messiy

    {"project":"BioNLP16_Messiy","denotations":[{"id":"T490","span":{"begin":59,"end":66},"obj":"Binding"},{"id":"T491","span":{"begin":160,"end":170},"obj":"Gene_expression"},{"id":"T492","span":{"begin":120,"end":128},"obj":"Positive_regulation"},{"id":"T462","span":{"begin":12,"end":16},"obj":"Protein"},{"id":"T463","span":{"begin":102,"end":106},"obj":"Protein"},{"id":"T464","span":{"begin":132,"end":155},"obj":"Protein"},{"id":"T465","span":{"begin":156,"end":158},"obj":"Protein"}],"relations":[{"id":"R127","pred":"themeOf","subj":"T491","obj":"T492"},{"id":"R128","pred":"themeOf","subj":"T491","obj":"T492"},{"id":"R255","pred":"themeOf","subj":"T463","obj":"T490"},{"id":"R256","pred":"themeOf","subj":"T464","obj":"T491"},{"id":"R257","pred":"themeOf","subj":"T465","obj":"T491"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    DLUT931

    {"project":"DLUT931","denotations":[{"id":"T610","span":{"begin":59,"end":66},"obj":"Binding"},{"id":"T611","span":{"begin":160,"end":170},"obj":"Gene_expression"},{"id":"T612","span":{"begin":120,"end":128},"obj":"Positive_regulation"},{"id":"T582","span":{"begin":12,"end":16},"obj":"Protein"},{"id":"T583","span":{"begin":102,"end":106},"obj":"Protein"},{"id":"T584","span":{"begin":132,"end":155},"obj":"Protein"},{"id":"T585","span":{"begin":156,"end":158},"obj":"Protein"}],"relations":[{"id":"R148","pred":"themeOf","subj":"T611","obj":"T612"},{"id":"R307","pred":"themeOf","subj":"T585","obj":"T611"},{"id":"R147","pred":"themeOf","subj":"T611","obj":"T612"},{"id":"R304","pred":"themeOf","subj":"T582","obj":"T610"},{"id":"R305","pred":"themeOf","subj":"T583","obj":"T610"},{"id":"R306","pred":"themeOf","subj":"T584","obj":"T611"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    bionlp-st-ge-2016-test-ihmc

    {"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T764","span":{"begin":75,"end":115},"obj":"Entity"},{"id":"T772","span":{"begin":9,"end":16},"obj":"Protein"},{"id":"T779","span":{"begin":202,"end":232},"obj":"Entity"},{"id":"T786","span":{"begin":98,"end":115},"obj":"Entity"},{"id":"T787","span":{"begin":202,"end":208},"obj":"Entity"},{"id":"T793","span":{"begin":145,"end":159},"obj":"Entity"},{"id":"T795","span":{"begin":209,"end":226},"obj":"Entity"},{"id":"T799","span":{"begin":102,"end":106},"obj":"Protein"},{"id":"T802","span":{"begin":129,"end":170},"obj":"Protein"},{"id":"T809","span":{"begin":132,"end":136},"obj":"Protein"},{"id":"T735","span":{"begin":156,"end":158},"obj":"Protein"},{"id":"T744","span":{"begin":183,"end":184},"obj":"Entity"},{"id":"T750","span":{"begin":29,"end":30},"obj":"Entity"},{"id":"T754","span":{"begin":67,"end":74},"obj":"Protein"},{"id":"T821","span":{"begin":117,"end":170},"obj":"Positive_regulation"},{"id":"T822","span":{"begin":59,"end":115},"obj":"Binding"}],"relations":[{"id":"R199","pred":"partOf","subj":"T786","obj":"T799"},{"id":"R333","pred":"themeOf","subj":"T754","obj":"T822"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    bionlp-st-ge-2016-test-tees

    {"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T532","span":{"begin":12,"end":16},"obj":"Protein"},{"id":"T533","span":{"begin":70,"end":74},"obj":"Protein"},{"id":"T534","span":{"begin":102,"end":115},"obj":"Protein"},{"id":"T535","span":{"begin":2,"end":8},"obj":"Gene_expression"},{"id":"T536","span":{"begin":59,"end":66},"obj":"Binding"},{"id":"T537","span":{"begin":59,"end":66},"obj":"Binding"},{"id":"T539","span":{"begin":132,"end":144},"obj":"Protein"}],"relations":[{"id":"R274","pred":"themeOf","subj":"T532","obj":"T535"},{"id":"R275","pred":"themeOf","subj":"T532","obj":"T536"},{"id":"R276","pred":"themeOf","subj":"T533","obj":"T536"},{"id":"R277","pred":"themeOf","subj":"T533","obj":"T537"},{"id":"R278","pred":"themeOf","subj":"T534","obj":"T537"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    testone

    {"project":"testone","denotations":[{"id":"T47","span":{"begin":12,"end":16},"obj":"Protein"},{"id":"T48","span":{"begin":102,"end":106},"obj":"Protein"},{"id":"T49","span":{"begin":132,"end":155},"obj":"Protein"},{"id":"T50","span":{"begin":156,"end":158},"obj":"Protein"},{"id":"T74","span":{"begin":59,"end":66},"obj":"Binding"},{"id":"T75","span":{"begin":107,"end":115},"obj":"Entity"},{"id":"T76","span":{"begin":120,"end":128},"obj":"Positive_regulation"},{"id":"T77","span":{"begin":145,"end":155},"obj":"Negative_regulation"},{"id":"T78","span":{"begin":160,"end":170},"obj":"Gene_expression"}],"relations":[{"id":"R6","pred":"themeOf","subj":"T49","obj":"T78"},{"id":"R7","pred":"equivalentTo","subj":"T50","obj":"T49"},{"id":"R23","pred":"themeOf","subj":"T75","obj":"T74"},{"id":"R24","pred":"partOf","subj":"T75","obj":"T48"},{"id":"R25","pred":"themeOf","subj":"T77","obj":"T76"},{"id":"R26","pred":"themeOf","subj":"T78","obj":"T76"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}

    test3

    {"project":"test3","denotations":[{"id":"T108","span":{"begin":12,"end":16},"obj":"Protein"},{"id":"T109","span":{"begin":102,"end":106},"obj":"Protein"},{"id":"T110","span":{"begin":132,"end":155},"obj":"Protein"},{"id":"T111","span":{"begin":156,"end":158},"obj":"Protein"},{"id":"T148","span":{"begin":12,"end":16},"obj":"Protein"},{"id":"T149","span":{"begin":59,"end":66},"obj":"Binding"},{"id":"T150","span":{"begin":102,"end":106},"obj":"Protein"},{"id":"T151","span":{"begin":120,"end":128},"obj":"Positive_regulation"},{"id":"T152","span":{"begin":132,"end":155},"obj":"Protein"},{"id":"T153","span":{"begin":156,"end":158},"obj":"Protein"},{"id":"T154","span":{"begin":160,"end":170},"obj":"Gene_expression"}],"relations":[{"id":"R50","pred":"themeOf","subj":"T148","obj":"T149"},{"id":"R52","pred":"themeOf","subj":"T152","obj":"T154"},{"id":"R53","pred":"equivalentTo","subj":"T153","obj":"T152"},{"id":"R54","pred":"themeOf","subj":"T154","obj":"T151"}],"text":"l amount of IL-8 (peak at 18 h: 5000 pg/ml), likely due to binding of NFκB to a consensus site in the IL-8 promoter. An increase in IL-1receptor antagonist(RA) production (peak at 24 h: 12000 pg/ml) by glucan phosphate-treated cells positively correlated with IL"}